Searched over 200M research papers
10 papers analyzed
These studies suggest that genetic factors significantly influence stroke risk and outcomes, with various genetic loci and variants linked to different stroke subtypes and recovery outcomes.
14 papers analyzed
20 papers analyzed
Stroke is a leading cause of long-term disability and death worldwide, characterized by its complex and multifactorial nature. While traditional risk factors such as hypertension, smoking, and physical inactivity are well-documented, recent research has increasingly highlighted the significant role of genetic factors in stroke susceptibility and outcomes .
Single-gene disorders can cause rare hereditary conditions where stroke is a primary manifestation. Additionally, common genetic polymorphisms have been linked to more prevalent causes of stroke, such as atrial fibrillation and large artery atherosclerosis . Recent studies have identified approximately 35 genetic loci associated with stroke risk, revealing novel mechanisms and pathways involved in stroke pathogenesis.
GWAS have been instrumental in uncovering genetic variants associated with stroke. For instance, a meta-analysis identified a novel locus at chromosome 6p25 (near FOXF2) associated with increased stroke susceptibility and cerebral small vessel disease. Other significant loci include ABO for all ischemic stroke, HDAC9 for large vessel disease, and PITX2 and ZFHX3 for cardioembolic stroke .
Genetic factors also play a crucial role in determining stroke outcomes. Variants such as the APOE4 allele and BDNF-196 locus have been associated with poor recovery following ischemic stroke and intracerebral hemorrhage. These findings underscore the importance of genetic screening in predicting patient prognosis and tailoring individualized treatment plans.
The recovery process post-stroke is influenced by genetic variants. For example, the presence of the APOE4 allele has been linked to unfavorable outcomes in intracerebral hemorrhage patients, while variants in the BDNF and CYP2C19 genes affect recovery in ischemic stroke patients. Understanding these genetic influences can help in developing targeted rehabilitation strategies.
The integration of genetic data into precision medicine holds promise for improving stroke prevention and treatment. Genome-wide polygenic scores can identify high-risk individuals before the onset of vascular risk factors, enabling early intervention. Additionally, ongoing research aims to better understand rare genetic variants and their impact on stroke recurrence and outcomes .
Emerging techniques such as exome content analysis, next-generation sequencing, and whole genome sequencing are expected to enhance our understanding of stroke genetics. These methods, combined with large international consortia efforts, will likely uncover new genetic factors and therapeutic targets .
Genetic factors significantly contribute to stroke risk and recovery, with both single-gene disorders and common genetic variants playing crucial roles. Advances in genetic research and precision medicine offer promising avenues for early identification, prevention, and personalized treatment of stroke. Continued exploration of genetic influences will be essential in reducing the global burden of this debilitating condition.
Most relevant research papers on this topic